VADUZ, Liechtenstein, 26 January 2021 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, based on the company’s proprietary anti-biofilm formulation NitrAdine®, shows high efficacy in reducing gingival inflammation in periodontically affected patients wearing fixed partial dentures. Researchers at the faculty of Dentistry, University of Medicine and Pharmacy, Timosoara, Romania studied a group of 49 patients who were instructed to brush their teeth, gums...
Author: bonyf
bonyf’s NitrAdine® disinfecting denture tablets proven to have the highest efficacy in reducing multispecies biofilm present on dentures
VADUZ, Liechtenstein, 8 January 2021 – A recent study by the Dental School of the University of Sao Paulo in Brazil published in the scientific journal “Gerondontology”, reported on the efficacy of bonyf’s NitrAdine® disinfecting effervescent denture tablets (“NitrAdine® tablets”). The study compared bonyf’s NitrAdine® tablets and Fixodent’s effervescent tablets in relation to reducing pathogenic...
PerioTabs® kills coronavirus that causes COVID-19
VADUZ, Liechtenstein, 16 Oct 2020 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, has proven virucidal efficacy against enveloped viruses after 2 minutes of contact. The study report was issued by an independent certified laboratory in accordance with the European Standard EN 14476 on DNA vaccinia virus (the reference virus for all enveloped viruses,...
bonyf initiates clinical studies for the evaluation of the efficacy of PerioTabs® for the treatment/prevention of gingivitis in young adults wearing fixed orthodontic braces
VADUZ, Liechtenstein, 27 Oct 2019, bonyf’s CSO, Dr Bart De Wever initiated two new clinical studies to evaluate the efficacy of PerioTabs® in patients wearing fixed orthodontic braces suffering from severe gingivitis.
Evidence that OlivaFix® Gold Denture Adhesive Cream reduces growth of Candida albicans presented at the 2019 World Congress in Barcelona, Spain
BARCELONA, Spain, 10 Oct 2019 – The Complutense University of Madrid in Spain recently completed a clinical trial evaluating OlivaFix® Gold Denture Adhesive Cream (OlivaFix® Gold) and a leading denture fixative cream brand with 40 denture wearers from both Spain and Portugal.
Superior results for OlivaFix® Gold Denture Adhesive Cream in large multi-centre clinical trial
VADUZ, Liechtenstein, 21 August 2019 - OlivaFix® Gold, an organic olive oil-based denture adhesive cream, free of mineral oil, Vaseline and zinc was recently evaluated in a clinical trial...
Mr Timothy Foubert appointed as Chief Financial Officer
VADUZ, Liechtenstein, 1 Aug 2019 – In a move to strengthen the company's management team, Mr Timothy Foubert was recently appointed as the Chief Financial Officer of bonyf AG.
bonyf’s latest innovative product PerioTabs® – described as a “miracle product”
BELGIUM, 20 June 2019 - The leading Belgian newspaper “Het Nieuwsblad” recently published an article on PerioTabs®, bonyf’s innovative product that helps reduce gum disease...
CSO for bonyf presents PerioTabs® at the 2019 “DENTis” International Congress of Dental Medicine for Students and Young Dentists conference in Romania
CLUJ-NAPOCA, Romania, 21 March 2019 - Dr Bart De Wever, CSO of bonyf presented a lecture on PerioTabs®...